The Patent Finder

Expression Genetics, Inc.

Also on record
Records under this name other than patents Expression Genetics, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Back to Expression Genetics, Inc.

PatentTitleStatus Expires Confidence
US 7,964,571Combination of immuno gene therapy and chemotherapy for treatment of cancer and hyperproliferative diseases
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 9,468,687Immuno gene therapy for treatment of cancer and hyperproliferative diseases
Formerly held
Term ended
Term ended Feb 7, 2026 · From the USPTO record
Term endedTerm ended Feb 7, 2026From the USPTO record
US 8,623,837Combination of immuno gene therapy and chemotherapy for treatment of cancer and hyperproliferative diseases
Formerly held
Term ended
Term ended Dec 24, 2025 · From the USPTO record
Term endedTerm ended Dec 24, 2025From the USPTO record
US 8,445,017Biodegradable cross-linked cationic multi-block copolymers for gene delivery and methods of making thereof
Formerly held
Term ended
Term ended Jan 24, 2025 · From the USPTO record
Term endedTerm ended Jan 24, 2025From the USPTO record
US 7,374,930GLP-1 gene delivery for the treatment of type 2 diabetes
Formerly held
Term ended
Term ended Jul 25, 2024 · From the USPTO record
Term endedTerm ended Jul 25, 2024From the USPTO record
US 8,057,821Biodegradable cross-linked cationic multi-block copolymers for gene delivery and methods of making thereof
Formerly held
Lapsed on the fee record
Ended Nov 15, 2023 · From the USPTO record
Lapsed on the fee recordEnded Nov 15, 2023From the USPTO record
US 6,586,524Cellular targeting poly(ethylene glycol)-grafted polymeric gene carrier
Formerly held
Term ended
Term ended Jul 19, 2021 · From the USPTO record
Term endedTerm ended Jul 19, 2021From the USPTO record
US 6,652,886Biodegradable cationic copolymers of poly (alkylenimine) and poly (ethylene glycol) for the delivery of bioactive agents
Formerly held
Term ended
Term ended Feb 16, 2021 · From the USPTO record
Term endedTerm ended Feb 16, 2021From the USPTO record
US 6,696,038Cationic lipopolymer as biocompatible gene delivery agent
Formerly held
Term ended
Term ended Sep 14, 2020 · From the USPTO record
Term endedTerm ended Sep 14, 2020From the USPTO record
US 6,177,274Hepatocyte targeting polyethylene glyco-grafted poly-L-lysine polymeric gene carrier
Formerly held
Term ended
Term ended May 20, 2019 · From the USPTO record
Term endedTerm ended May 20, 2019From the USPTO record
10 of 12 patents shown.
Pro members see all 12.
Pro members: see all 12 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited